Comparison of a One- versus Two-Week Treatment with Famciclovir Upon Reductions in Pain and Occurrence of Postherpetic Neuralgia in Herpes Zoster: A Randomized Open-Label Trial

Background: Herpes zoster (HZ) is an acute herpetic skin disease resulting from the varicella-zoster virus. Typically, this condition is treated with a one-week administration of antiviral drugs, including famciclovir, which can effectively control the symptoms during the acute phase and prevent the occurrence of postherpetic neuralgia (PHN).Objective: To investigate whether a longer, two-week, regimen would enhance the capacity for famciclovir to reduce pain and prevent the occurrence of postherpetic neuralgia.Methods: HZ patients were randomly divided into two groups who were treated with famciclovir for either a one-or two-week period. Following their respective famciclovir treatments, patients were assessed for potential differences in pain intensity as evaluated at 1, 2, 4, 8 and 12 weeks post-treatment. In addition, the occurrence of postherpetic neuralgia at three months after treatment was compared between the two groups.Results: Of the 86 patients initially enrolled, 80 completed the study with N=40 randomly assigned to each of the two groups. Pain scores decreased significantly at 1, 2, 4, 8 and 12 weeks after famciclovir treatments. There were no significant differences in pain scores, and the incidence of postherpetic neuralgia occurrence between the two groups. There were no statistically significant differences in reducing pain intensity or frequency of postherpetic neuralgia between the one-week and two-week treatment protocols.Conclusion: It suggests that longer administration of famciclovir has no further benefit in the treatment of herpes zoster in our study.

Automated summary

This study investigated the efficacy of longer administration of famciclovir in reducing pain and preventing postherpetic neuralgia. Two groups of patients were treated with famciclovir for either one or two weeks, and their pain intensity and occurrence of postherpetic neuralgia were evaluated at different time points. The results showed no significant differences between the one-week and two-week treatment protocols in reducing pain intensity and frequency of postherpetic neuralgia.